Abstract
Common cardiovascular surgeries include coronary artery bypass grafting, cardiac valve replacement, radiofrequency ablation, and cardiac intervention surgery. Multiple postoperative complications, such as hypoxic encephalopathy, air embolism, retained intracardiac air, cognitive dysfunction and major adverse cardiovascular events, including heart failure, ischemic stroke, and myocardial infarction, may occur after these cardiovascular surgeries. Hyperbaric oxygen can be used in preconditioning to lower the morbidity of adverse complications. It is also effective for the treatment of numerous postoperative complications. We provide evidence from the current literature highlighting the use of hyperbaric oxygen therapy for preconditioning and managing postoperative complications.
Keywords: air embolism, cardiovascular surgery, cognitive dysfunction, cognitive dysfunction, extracorporeal circulation, heart failure, hyperbaric oxygen, hypoxic encephalopathy, hypoxic encephalopathy, infective endocarditis, low cardiac output syndrome, sudden sensorineural hearing loss
Introduction
Cardiovascular surgeries can improve patients’ survival rate, restore their cardiovascular function and, most importantly, enhance their quality of life. Various cardiovascular surgeries, such as cardiac valve replacements, coronary artery bypass grafting (CABG), and heart transplants, are widely used in our daily lives. For example, valve replacement and myocardial revascularization are the most common surgeries performed on Brazilian adults.1 Moreover, various postoperative complications accompany these surgeries (Table 1).2,3,4,5,6,7,8,9,10,11 These include air embolism, sternal wound infection, postoperative cognitive dysfunction (POCD), hypoxic encephalopathy, atrial fibrillation, and pericardial effusion.6 These complications strongly affect patient survival rates and the length of hospital stay. Timely application of multifactorial nonpharmacologic and pharmacologic treatments can improve patient prognosis to some extent.
Table 1.
Complications of different cardiovascular surgeries
| Complication | Morbidity | Adverse outcome | Treatment | Reference |
|---|---|---|---|---|
| Acute kidney injury (especially in elderly) | 37.5% in elderly | Adverse renal, cardiovascular, and respiratory outcomes, and even death | Renal replacement therapy, fluid management, vasopressor therapy | 2 3 |
| Sternal wound infection | 0.5–8% in superficial sternal wound infection, 0.5–6.8% in deep sternal wound infection | Significant reduction in long- and midterm survival rate | Vacuum-assisted closure therapy, wound debridement, irrigation antibiotic | 4 5 |
| Atrial fibrillation | 6% of patients who received heart transplantation within 60 d | Heart failure, cerebrovascular embolism | Magnesium sulphate, catheter ablation | 6 7 |
| Postoperative delirium | 29.8–39% | Conscious impairment, attention deficits and longer hospitalization | Multicomponent nonpharmacologic intervention | 8 |
| Pericardial effusion | Over 20% of patients during the first month | Longer hospitalization and increased early mortality rate | Pericardiocentesis, pericardiotomy | 6 9 |
| Postoperative cognitive dysfunction | Total incidence is up to 70% | Cognitive decline, dementia, higher hospitalization expenses | Medication such as anti-inflammatory and immunosuppressive agents | 10 11 |
Hyperbaric oxygen (HBO) involves taking in 100% oxygen at an elevated pressure above 1 absolute atmospheric pressure (ATA; 1 ATA = 101.325 kPa).12 It can increase internal oxygen partial pressure and increase the blood solubility of oxygen to elicit diverse therapeutic effects. HBO is widely used in clinical applications, including carbon monoxide poisoning, decompression sickness, radiation injury, and ischemic disease. This review focuses on the application of HBO in preconditioning and therapy for cardiovascular postoperative complications (Figure 1).
Figure 1.

Timeline showing the important application of hyperbaric oxygen in cardiovascular surgery mentioned in the review.
Akt: Protein kinase B; CABG: coronary artery bypass grafting; HIF-1α: hypoxia inducible factor-1α; HO-1: heme oxygenase 1; HT: hemorrhagic transformation; ICU: intensive care unit; LCOS: low cardiac output syndrome; Nrf2: nuclear factor erythroid 2-related factor 2; POCD: postoperative cognitive dysfunction; ROS: reactive oxygen species; SSNHL: sudden sensorineural hearing loss.
Search Strategy
The authors used the terms “cardiovascular surgery” and “cardiac surgery” together with “complications” to search for literature in the PubMed database from January 1965 to December 2024. We are aware of common cardiovascular postoperative complications, such as postoperative cognitive dysfunction, hemorrhagic transformation, myocardial ischemia‒reperfusion injury, acute kidney injury, hypoxic encephalopathy, air embolism, wound infection, infective endocarditis, low cardiac output syndrome, sudden sensorineural hearing loss, and heart failure. These complications were used as new search terms. They were searched separately and screened on the basis of their relevance to obtain literature introducing the etiology and pathophysiology of these complications. After that, we retrieved these complication terms together with the term “hyperbaric oxygen” and further screened them by reading the literature titles and abstracts. Ultimately, we used these articles to elucidate the mechanism and efficacy of hyperbaric oxygen therapy for these complications.
Application of Hyperbaric Oxygen Preconditioning in Cardiovascular Surgery
HBO preconditioning refers to exposure to HBO before noxious stimulation to provide a prophylactic condition. Research has shown that it may imitate hypoxic preconditioning and induce ischemic tolerance to attenuate ischemia‒reperfusion injury without adverse effects.13,14 The application of HBO preconditioning in cardiovascular surgery is shown in Table 2.15,16,17,18,19
Table 2.
Hyperbaric oxygen preconditioning applications
| Complication | Duration | Pressure | Times | Measure | Outcome | Reference |
|---|---|---|---|---|---|---|
| POCD | Two 30 min, interval 5 min | 2.4 ATA | Once daily for 3 d | CD18, HSP 70, infarct volume, hemoglobin content | Decrease in the incidence of POCD and inflammation | 15 |
| HT | 1 h | 2.5 ATA | Once daily for 5 d | HO-1, Nrf2, infract volume, neurological behavior test | Decrease infarct volume and HT incidence, improve neurological deficits | 16 |
| MIRI | 1 h | 2 ATA | Four times daily | HO-1, Nrf2, Akt, infarct volume | Ameliorate cardiac function and decrease infarct volume | 17 |
| CABG | Two 30 min, interval 5 min | 2.4 ATA | Once 4 h prior to CABG | Hemodynamics, troponin T, clinical symptoms | Reduct hospital stays, reduce bleeding volume, inflammation and other complications | 18 |
| AKI | 1 h | 2 ATA | Twice daily | 3-NT, NF-κB, γH2AX(S139) histone | Enhance antioxidant capacity and reduce kidney DNA damage | 19 |
3-NT: 3-Nitrotyrosine; AKI: acute kidney injury; Akt: protein kinase B; ATA: absolute atmospheric pressure; CABG: coronary artery bypass grafting; CD18: cluster of differentiation 18; HO-1: heme oxygenase 1; HSP 70: heat shock protein 70; HT: hemorrhagic transformation; MIRI: myocardium ischemia–reperfusion injury; NF-κB: nuclear factor κB; Nrf2: nuclear factor erythroid 2-related factor 2; POCD: postoperative cognitive dysfunction; γH2AX(S139): histone H2AX at serine 139.
The mechanism of HBO preconditioning might involve the activation of antioxidant enzymes and related genes in the central nervous system, including catalase, superoxide dismutase, and nitric oxide synthase. Then, increased nitric oxide can initiate the nitric oxide/protein kinase G pathway by activating soluble guanylate cyclase, ultimately leading to the inhibition of the MPTP and a reduction in cell death.20,21 It can also stabilize glucose levels and decrease the lactate/pyruvate ratio and glycerol levels in the infarcted area while restricting the increase in glutamate levels. Increasing energy metabolism and reducing glutamate levels are crucial factors contributing to the neuroprotective effects of HBO preconditioning.14
An animal experiment indicated that daily 1 hour HBO preconditioning with 2 ATA for 5 days enhances the tolerance of cerebral ischemic neurological injury in hamsters; this phenomenon is closely associated with heat shock protein 72.13 In another clinical study involving newborns as subjects, daily HBO preconditioning with 2.5 ATA for 2.5 hours reduced the infarction area by inhibiting caspase-3 and caspase-9 activities.14
Effects of hyperbaric oxygen preconditioning on cognitive dysfunction
POCD is a common complication following cardiovascular surgery. Research has shown that the incidence of POCD can reach 40% within 1 week and 17% within 3 months after cardiovascular surgery.22 It usually represents a decrease in memory, attention and cognitive performance. According to Gao et al.’s study,23 the mechanism of POCD might involve neuroinflammation caused by surgery, and central cholinergic deficiency is also an essential reason.
HBO preconditioning is a useful method for POCD treatment. It has been shown to enhance postoperative cognitive function and reduce the occurrence of POCD. HBO preconditioning can also produce effective cardiovascular protection, ameliorate patients’ attention dysfunction and improve their spatial learning and memory skills.24,25
Alex et al.15 indicated that the plasma concentrations of neurological injury markers, such as soluble E-selectin, CD18, and heat shock protein 70, in patients who underwent HBO preconditioning before surgery were significantly lower than those in the control group. The decreases in these markers indicate that HBO preconditioning has cerebral and cardioprotective effects. Sun et al.26 indicated that HBO preconditioning can greatly ameliorate the serum concentration of proinflammatory cytokines, e.g., caspase-3, and improve the integrity of the blood‒brain barrier (BBB). Animal experiments have shown that Sirt1 may be an important molecular target for HBO preconditioning.27
Furthermore, studies suggest that HBO preconditioning can be utilized either independently or in combination with other preconditioning treatments, such as remote ischemic preconditioning or edaravone, to protect patients prior to cardiac valve replacement surgery and mitigate the occurrence of POCD. The underlying mechanism may involve a reduction in inflammatory factor levels and alleviation of central nervous system damage caused by inflammatory responses.28,29,30
Hyperbaric oxygen preconditioning on hemorrhagic transformation
Hemorrhagic transformation (HT) is a common complication that occurs after AIS, while cardioembolic stroke is related to the highest frequency of HT. HT refers to the conversion of ischemic brain tissue into hemorrhagic lesions. It is usually accompanied by vascular leakage, resulting in brain injury. According to a previous study, HT has a morbidity of 42% in patients who have prosthetic valve endocarditis.31 Postoperative complications of cardiovascular surgery, such as atrial fibrillation and myocardial infarction, are critical factors related to HT. The possible reason is that these complications may exacerbate hypoperfusion.32
HBO preconditioning is a noteworthy method for HT treatment (Figure 2). It can improve BBB permeability and neurological function and decrease the incidence of HT after AIS.16 The mechanism of HBO preconditioning might be related to the increase in hypoxia inducible factor-1α (HIF-1α). HIF-1α is a specific transcription factor that becomes active under hypoxic conditions. Under normal circumstances, it undergoes proline hydroxylation by proline hydroxylase and subsequent ubiquitination and degradation by the proteasome. Under hypoxic conditions, reduced proline hydroxylase activity prevents normal hydroxylation and degradation of HIF-1α, leading to its accumulation along with HIF-1β; these then bind together to induce the activation of hypoxia adaptation genes within the cell nucleus. The oxygen content decreased to a normal level at 21% after HBO preconditioning. This leads to relatively hypoxic conditions in brain tissues, which can promote the production of HIF-1α. The cycle of hyperoxia followed by hypoxia caused by repeated HBO preconditioning may contribute to the accumulation of HIF-1α.14
Figure 2.

Mechanism of hyperbaric oxygen preconditioning for hemorrhagic transformation.
Some of the image materials are from biogdp.com. HIF: Hypoxia inducible factor.
Hyperbaric oxygen preconditioning on myocardium ischemia–reperfusion injury
Acute myocardial infarction (AMI) is a worldwide disease that threatens human health. The best treatment for acute myocardial infarction is timely reperfusion therapy, such as percutaneous coronary intervention and CABG. However, reperfusion therapy itself can induce myocardium ischemia‒reperfusion injury (MIRI), causing further death of myocardial cells and worsening patient prognosis.33
Effective interventions for MIRI prevention are urgently needed. Luckily, HBO preconditioning might be useful for MIRI treatment. A previous study revealed that HBO preconditioning (2 ATA, four times a day) 5 days before surgery can mitigate the degree of hemorrhage, necrosis and infiltration of neutrophils.17 It can also reduce the infarction area and reverse the elevation of left ventricular systolic pressure and left ventricular developed pressure caused by MIRI. In addition, HBO preconditioning can decrease the levels of inflammatory factors such as myeloperoxidase, tumor necrosis factor α, interleukin (IL)-1β and oxidative markers (malondialdehyde, protein carbonyl, 8-hydroxy-2-deoxyguanosine), which suggests that HBO preconditioning has anti-inflammatory and antioxidant effects.
Moreover, Yin et al.17 found that HBO preconditioning can activate the phosphatidylinositol 3-kinase/serine/protein kinase B (Akt) pathway and significantly increase the concentrations of nuclear factor erythroid 2-related factor 2, heme oxygenase 1 (HO-1), and Akt. This activation helps protect patients from MIRI.
Hyperbaric oxygen preconditioning for coronary artery bypass grafting
HBO preconditioning can provide cerebral and cardiovascular protection and shorten hospital stays. In addition, it can ameliorate cardiac function and adverse outcomes.
On the basis of a clinical study, HBO preconditioning does not confer a protective effect on patients undergoing off-pump CABG.34 However, for patients undergoing on-pump CABG, HBO preconditioning has the potential to mitigate the release of neurological and cardiac injury markers, such as S100 calcium binding protein β, troponin I, and neuron-specific enolase, and can activate a protective antioxidation pathway that depends on increased catalase activity. The data indicate that postoperative intensive care unit hospital stays are significantly shorter in patients who receive on-pump CABG with HBO preconditioning, accompanied by a decrease in composite cardiovascular adverse events.
HBO preconditioning has the capacity to improve patients’ hemodynamics and reduce postoperative complications. Patients are exposed to 100% oxygen at 2.4 ATA 70 minutes daily for 5 days prior to CABG, and their perioperative hemodynamics are assessed via pulmonary artery catheterization. Compared with the control group, those subjected to HBO preconditioning presented lower pulmonary vascular resistance, increased stroke volume and greater left ventricular stroke work. Furthermore, intensive care unit hospital stays for the HBO preconditioning group were shortened by 18%, indicating that the HBO preconditioning approach had protective effects on the myocardium. The intraoperative bleeding volume was reduced by 57% in the HBO preconditioning group, and the postoperative bleeding volume was reduced by 11.6%. Additionally, the incidence of atrial fibrillation decreased by 11%, that of low cardiac output syndrome (LCOS) decreased by 10.4%, that of inotrope usage decreased by 8%, and that of infection complications decreased by 7.6%.35
HBO preconditioning can induce oxidative stress, leading to an increase in reactive oxygen species (ROS) generation. However, part of its therapeutic effect could also be associated with increased quantities of nitric oxide synthase and heat shock protein 72 due to increased ROS concentrations.18 Research has shown that the serum concentration of troponin T, a marker of myocardial injury, does not increase after 1 hour or more of HBO preconditioning.18 Yogaratnam et al.35 These findings suggest that HBO preconditioning results in a smaller increase in troponin T following CABG and that troponin T levels tend to stabilize 2 hours after cardiopulmonary bypass (CPB), suggesting that HBO can mitigate myocardial necrosis and troponin T release. These results reveal that HBO preconditioning is a safe intervention method and does not lead to clinically detectable myocardial injury.
Hyperbaric oxygen preconditioning in acute kidney injury
Acute kidney injury (AKI) is a common complication after cardiovascular surgery. It has a high incidence rate in elderly patients because of the aging of the kidney and nosocomial infection. Cardiovascular surgery is the second leading cause of AKI in the intensive care unit.2 Many factors in cardiovascular surgery can cause AKI, including ischemia‒reperfusion injury, oxidative stress, apoptosis, inflammatory reactions, and calcium overload.19,36
HBO preconditioning is regarded as an effective way to ameliorate AKI. It can improve renal hemodynamics by increasing renal blood flow and reducing renal vascular resistance. HBO preconditioning can also reduce oxidative and inflammatory reactions, decrease DNA damage and cell apoptosis, and even improve renal histological structure. In addition, phosphate clearance, creatinine, blood urea nitrogen and renal function were notably improved after HBO preconditioning.19,36
According to Nesovic Ostojic’s study,19 HBO preconditioning before the AKI model is constructed can increase the estimated glomerular filtration rate. The plasma antioxidant capacity measured by ferric reducing antioxidant power and 2,2′-azino-bis(3-ethylbenzothiazoline-6 sulfonic acid) assays was elevated at the same time. In the control group, 3-nitrotyrosine, an oxidative damage marker, was strongly expressed in the renal tubules and in the glomeruli, while its level in the HBO preconditioning group was significantly reduced. Nuclear factor-κB and histone H2AX at serine 139 were also abundantly expressed in the nuclei of proximal tubular epithelial cells in the control group, and their concentrations also decreased in the HBO preconditioning group. 3-Nitrotyrosine is a product of oxidative posttranslational modification and is associated with high levels of ROS. Histone H2AX at serine 139 is associated with DNA damage. These results suggest that HBO preconditioning ameliorates oxidative stress and protects DNA. HBO preconditioning can induce intermittent high oxygen-related hypoxia, leading to a moderate increase in ROS, which further activates downstream signaling pathways and upregulates antioxidant enzymes.
Moreover, other studies have shown that HBO preconditioning can increase the expression of HO-1. The cell protective effect of HO-1 is related to an increase in the antiapoptotic proteins Bcl-2 and Bcl-xl and a decrease in the proapoptotic proteins caspase-3, caspase-9, and Bax. The overexpression of Bcl-2 can prevent the release of mitochondrial cytochrome c and reduce cell apoptosis. HBO preconditioning can also improve AKI histologically, such as making renal tubular epithelial cell lesions milder, decreasing renal tubular dilation, and decreasing Perodic acid Schiff’s reaction-positive casts. A previous study demonstrated that HBO can ameliorate AKI at the histological level and reduce damage caused by cell apoptosis.36
Application of Hyperbaric Oxygen Therapy for Postoperative Complications
CPB is a milestone technology in cardiovascular surgery. CPB establishes an extracorporeal circuit temporarily and substitutes the circulatory functions of the heart and lungs with the machine, allowing the heart to pause in the short term and creating a bloodless area and stationary heart for further precise surgical procedures.37 However, inflammation and coagulation reactions can be activated because of the contact between the blood and the operative wound as well as the CPB machine. These processes involve the activation of platelets, leukocytes and thrombin and can ultimately lead to systemic inflammatory response syndrome, edema, increased capillary permeability and organ failure.38 Moreover, inflammation and coagulation reactions can mutually promote each other, which makes the situation even worse.39 CPB also has other potential side effects, including MIRI, microemboli generation, endothelial injury and damage to the myocardial microcirculation.1,40 Therefore, CPB is a common factor contributing to various complications following cardiovascular surgery. HBO therapy can treat various complications after cardiovascular surgery, with specific pressures, times, and efficacies detailed in Table 3.41,42,43,44,45,46
Table 3.
The application of hyperbaric oxygen therapy
| Complication | Duration | Pressure | Times | Measure | Outcome | Reference |
|---|---|---|---|---|---|---|
| Hypoxic encephalopathy | 2 h | 2 ATA | Once daily | Clinical symptoms | Recovery of consciousness | 41 |
| Wound healing and infection | 90 min | 240 kPa | Once daily | C-reactive protein, CT, clinical symptoms | Wound closed and epithelialized, C-reactive protein count return to normal | 42 |
| Infective endocarditis | 90 min | 280 kPa | Twice daily | Bacterial load in the aortic valves, pro-inflammatory cytokines | Reduce inflammatory response, decrease bacterial load on heart valves, enhance the efficacy of tobramycin | 43 |
| LCOS | Not mentioned | 2 ATA | Not mentioned | Clinical symptoms, arterial- oxygen saturation and pH | Restore consciousness and start urinating, improvethe cyanosis and acidosis | 44 |
| SSNHL | 90 min | 2.5 ATA | Once daily | Clinical symptoms, audiograms | Complete recovery of hearing | 45 |
| Heart failure | 90 min | 2 ATA | Once daily | Left ventricular end-systolic volume, LVEF, myocardial performance index | Increase ventricular systolic function and myocardial function | 46 |
ATA: Absolute atmospheric pressure; LCOS: low cardiac output syndrome; LVEF: left ventricular ejection fraction; SSNHL: sudden sensorineural hearing loss.
Hyperbaric oxygen therapy for hypoxic encephalopathy after cardiovascular surgery
Hypoxic encephalopathy is a common complication and the main cause of death and disability after cardiovascular surgery. The extracorporeal circulation process, decreased blood pressure, air embolism and cardiac arrest are important causes of secondary hypoxic encephalopathy.41
When brain cells lack perfusion, their basic oxygen demand cannot be met, leading to both metabolic and functional disorders in brain cells. Furthermore, this can cause cerebral edema and even trigger cerebral hernia. Depending on the degree of damage, hypoxia encephalopathy can manifest as different symptoms ranging from consciousness disorders to vegetative states.47
According to a clinical study, six patients with hypoxic encephalopathy after cardiovascular surgery received HBO therapy daily for 2 hours at 2 ATA. Three patients recovered consciousness after receiving 3, 6, or 11 sessions of HBO therapy and were ultimately essentially cured. The other three patients died due to severe clinical symptoms such as coma and limb movement disorders before receiving HBO therapy.41
HBO elevates the oxygen partial pressure and dissolved oxygen content in the blood. The arterial blood oxygen content can reach 5.3–6.4 mL/100 mL when pure oxygen is inhaled at 0.3 MPa. This value is 20 times greater than the arterial blood oxygen content at normal atmospheric pressure. HBO can also quickly improve the hypoxic state of brain cells and increase the oxygen diffusion distance. Timely HBO therapy can improve the oxygen supply capacity of collateral circulation, block and even reverse further functional deterioration of surviving brain cells located in the ischemic penumbra.41
HBO therapy can alleviate cerebral injury caused by hypoxia through other methods in addition to increasing the oxygen supply. For example, HBO can lower the serum concentration of fibrinogen and increase negative charges on the surface of platelets and red blood cell production to reduce blood viscosity and platelet aggregation ability. It can also reduce lipid peroxidation, accelerate thrombus absorption and restore the activity of calcium pumps to transport excess calcium ions from the cell, abating damage to brain cells caused by calcium overload. Research has shown that HBO therapy is able to decrease the expression of c-Fos in cells within the cerebral infarction area to prevent the extrinsic and intrinsic apoptosis of brain cells initiated by Bax. Through these effects, HBO plays an important role in hypoxia encephalopathy therapy.48 The mechanism of HBO therapy for hypoxic encephalopathy is detailed in Figure 3.
Figure 3.

Mechanism of hyperbaric oxygen therapy for hypoxic encephalopathy.
Some of the image materials are from biogdp.com.
Hyperbaric oxygen therapy for air embolism after cardiovascular surgery
An ultrasonic study revealed that almost all patients develop microscopic cerebral artery air emboli after cardiovascular surgery. Air emboli can be generated during extracorporeal circulation, and the main risk of their formation is the opening of the left ventricle and the aorta during surgery, such as valve replacement.49 Air emboli can reach the lungs via the pulmonary circulation and cause pulmonary embolism; they can also reach the limbs, brain and other parts of the body via the systemic circulation. Depending on the size and location of the air embolism in the brain, various clinical symptoms can manifest, ranging from confusion, coma, seizures, and cardiopulmonary failure to local symptoms such as unilateral or bilateral sensorimotor dysfunction.
Ischemia and hypoxia may be direct damaging factors. Larger air bubbles can occupy the branching capillaries, causing the surface tension to increase and exceed the cerebral perfusion pressure, thus blocking or impeding blood flow. BBB dysfunction, water‒electrolyte imbalance and cerebral edema can lead to further damage. Air emboli can also induce endothelial injury, inflammatory reactions, and increased vascular resistance.50
HBO therapy is considered the definitive therapy for air embolism (Figure 4). It can reduce the volume of air embolism and alleviate endothelial injury, inflammatory reactions, and local edema.49 The Boyle‒Mariotte law is the principle behind this therapy, which states that at a fixed temperature, the pressure and volume of a gas are inversely proportional. Patients who receive HBO therapy inhale high-concentration oxygen to increase the oxygen partial pressure in the body and eliminate air emboli. At the same time, nitrogen in the air emboli can be replaced by oxygen in the blood, and then, oxygen is utilized by the surrounding tissues, thereby shrinking the air emboli.51
Figure 4.

Mechanism of hyperbaric oxygen therapy for air embolism.
Some of the image materials are from biogdp.com.
Blanc et al.52 indicated that patients treated with HBO within 6 hours after air embolism can achieve better outcomes than those treated with delayed therapy. These findings reveal the importance of early HBO therapy for air embolism. Blanc et al. also reported that HBO is more effective in treating venous air embolism than in treating arterial air embolism.
Effects of hyperbaric oxygen therapy on cognitive dysfunction after cardiovascular surgery
POCD is a complication that affects a single or multiple cognitive domains for a short or long period after surgery.53 The total incidence of POCD after cardiovascular surgery is as high as 70%.11 POCD can lead to reduced daily life skills, increased demand for nursing care and increased hospitalization costs, and the morbidity of dementia is also elevated.54 The development of POCD after cardiovascular surgery can be attributed to factors such as hypothermia and reduced perfusion during extracorporeal circulation, cerebral embolism, and inflammatory reactions.
HBO preconditioning can alleviate POCD, and HBO therapy can also have a therapeutic effect even after POCD occurs. It can directly increase the partial pressure of oxygen, increase the dissolved oxygen content of the blood, and expand the diffusion radius of oxygen, thereby improving tissue and systemic hypoxia.54
The protective effect of HBO therapy on surrounding cells within lesion areas is related to its ability to expedite collateral circulation establishment, promote blood capillary regeneration and improve local microcirculation. Furthermore, HBO therapy can mitigate cerebral edema and intracranial hypertension by constricting cerebral blood vessels and enhancing vertebral artery flow. These effects increase the oxygen partial pressure of the brainstem ascending reticular activating system, thus promoting awakening among comatose patients.55
Effects of hyperbaric oxygen therapy on wound healing and infection after cardiovascular surgery
Median sternotomy is a crucial procedure in cardiovascular surgery to approach the heart, but it can increase the morbidity of deep or superficial sternal wound infection and even rare yet severe inflammation and infection complications such as sternal mediastinitis and osteomyelitis. These complications can increase hospitalization expenses, prolong hospital stays and lead to death.5,56,57
HBO therapy can resist infection and promote wound healing and epithelialization. HBO therapy has good efficacy even when conventional debridement and antibiotic therapy are ineffective.42,58
Molecular oxygen can increase capillary angiogenesis and promote the generation of ATP, which is important in biosynthetic processes that occur in wounds.59 The hydroxylation of proline depends on the local oxygen concentration, and hydroxylated proline is the crucial raw material for the formation of stable collagen by fibroblasts. Ultimately, the continuously generated collagen can promote wound closure. These functions may explain why HBO therapy can accelerate wound healing.4
Prophylactic antibacterial effects could be achieved through HBO therapy after sternotomy. It can also reduce deep or superficial sternal infections following CABG. This effect may be attributed to the antibacterial properties of oxygen.59
Under HBO conditions, the oxygen binding capacity of hemoglobin is saturated; therefore, the blood oxygen-carrying capacity is improved by an increase in the plasma dissolved oxygen content. At high partial pressures of oxygen (100%, 3 ATA) over 24 hours, HBO has bactericidal effects on Pseudomonas aeruginosa, a common Proteus species, and Salmonella typhosa. Additionally, the lack of carbon dioxide enhances this effect. While the spores of Clostridium perfringens are resistant to HBO, HBO therapy can also prevent their germination. The bacterial killing mechanism of oxygen involves the reduction of molecular oxygen into superoxide anions, which have toxic effects. Elevated partial pressure of oxygen can enhance both enzymatic and nonenzymatic reduction reactions within bacteria. Superoxide anions also initiate the formation of other toxic ROS that contribute to bactericidal effects.” HBO therapy can also decrease the serum concentration of granulocyte colony-stimulating factor and IL-6 to induce immunomodulatory effects and reduce damage to patients due to inflammation triggered by infection.60,61
Hyperbaric oxygen therapy for infective endocarditis after cardiovascular surgery
Infective endocarditis (IE) is a serious complication after cardiovascular surgery, and the mortality of patients without treatment is almost 100%. IE refers to infection of the inner surface of the heart, and cardiovascular surgery, such as valve replacement, is one of the common reasons for IE. According to the research of Kahrovic et al.,62 among 576 patients who underwent aortic valve replacement, 1.4% developed IE. Other risk factors include intravascular catheterization, advanced age, and the use of cardiac implants.63
HBO therapy can treat IE as an adjuvant therapy through different mechanisms (Figure 5). For example, HBO therapy can increase the oxygen content in biofilms to activate bacteria and shorten the bacterial division time. Therefore, antibiotic drugs, including tobramycin, β-lactam antibiotics and fluoroquinolones, can work better. Elevated oxygen levels can also enhance the respiratory burst of leukocytes to kill bacteria.43,64 HBO therapy increases the generation of ROS, which can oxidize and destroy bacteria, proteins, lipids, and DNA, thereby increasing resistance to infections. A study showed that HBO therapy can lower the level of vascular endothelial growth factor to limit the expansion of valve vegetation caused by platelet aggregation.43 The secretion of signaling molecules such as von Willebrand factor, IL-6, and IL-8 by endothelial cells is also repressed in HBO therapy, and the expression of anti-inflammatory molecules such as IL-10 is increased; as a result, the inflammatory response is suppressed. HBO therapy is also capable of preventing bacteria from producing toxins. Research has shown that Clostridium perfringens stops producing α-toxins when the oxygen partial pressure reaches 250 mmHg, and the oxidative stress caused by HBO therapy can lead to inactivation of the hemolytic toxins of Staphylococcus aureus.63 Oter et al.65 These findings suggest that the therapeutic effect of HBO is dose dependent, but the specific mechanism still needs further exploration.
Figure 5.

Mechanism of hyperbaric oxygen therapy for infective endocarditis.
ROS: Reactive oxygen species.
Hyperbaric oxygen therapy for low cardiac output syndrome after cardiovascular surgery
LCOS is the most common and severe complication after cardiovascular surgery.66 Its incidence in adults ranges from 2% to 27%, and the incidence rate in children varies from 17% to 67%.24 The most common definition of LCOS is a cardiac index below 2.0 L/min/m2 and a systolic blood pressure below 90 mmHg and symptoms of insufficient tissue perfusion, such as oliguria, clammy skin and increased lactate concentration in the absence of hypovolemia. LCOS can lead to consequences such as atrial fibrillation, pulmonary complications, and acute kidney failure, and its mortality exceeds 20%.66,67
Yacoub et al.44 described HBO clinical treatment. A patient with preoperative pulmonary arterial hypertension presented typical symptoms of LCOS, including dyspnea and severe peripheral cyanosis 2 hours after surgery. The patient’s condition subsequently worsened, and typical symptoms of LCOS appeared, including cyanosis, decreased blood pressure, acidosis, and anuria. Blood transfusion and intermittent positive pressure ventilation therapy were ineffective for the patient, and it was ultimately decided to administer HBO therapy. The patient was sent to an HBO chamber and inhaled pure oxygen at two atmospheres. After receiving HBO therapy for 1 hour, the patient’s complexion began to improve, and after 12 hours, the patient regained consciousness for the first time and was able to start moving around. The patient’s condition improved significantly in the end, with only mild cyanosis. Acidosis was relieved, the arterial-blood pH increased to 7.37, and the patient began urinating after HBO therapy.
The treatment process of this case revealed that HBO therapy has a significant therapeutic effect on postoperative LCOS patients with preoperative pulmonary arterial hypertension. HBO therapy helps maintain sufficient total available oxygen with low cardiac output by increasing the amount of oxygen dissolved in the plasma. It can increase the oxygen supply to the lungs and reduce pulmonary artery constriction and pulmonary arterial hypertension caused by hypoxia, thus reducing the right heart load. HBO therapy can also alleviate the systemic inflammatory response, reduce myocardial damage, improve cardiac function, and increase cardiac output. Although HBO therapy has been shown to have significant effects on the LCOS in certain clinical cases, few studies have explored the role of HBO therapy in the treatment of LCOS. Therefore, the exact efficacy of HBO treatment for LCOS still requires extensive clinical trials and further research.
Hyperbaric oxygen therapy for sudden sensorineural hearing loss after cardiovascular surgery
Sudden sensorineural hearing loss (SSNHL) is an uncommon complication after cardiovascular surgery. SSNHL refers to sudden hearing loss of at least 30 decibels at three or more consecutive frequencies within 72 hours. Patients may experience symptoms such as tinnitus, nausea and vomiting. Although SSNHL is not fatal, it may have a significant effect on the quality of life of patients. When frequency loss occurs within the range of 500–3000 Hz, which is the frequency range most commonly heard by humans, patients may develop reactions such as insomnia and anxiety.68
SSNHL after cardiovascular surgery is more common in males and is often unilateral, and the left ear is more susceptible to impact. The cochlea has a high oxygen demand and is supplied by only a single terminal artery, making it susceptible to hypoxia. Hypoxia leads to ciliary fusion of cochlear hair cells, edema of synapses and dendrites, sustained depolarization, separation of hair cells from the capsule, and microcirculatory obstruction, ultimately resulting in hearing loss.68,69
According to Bruschi’s clinical case report,45 a patient who underwent coronary artery reimplantation and replacement of the aortic root and ascending aorta developed nasal congestion and left hearing loss on the seventh day after surgery. The audiogram revealed severe sensorineural hearing loss in the left ear of 60 dB at 1000 Hz, and the patient’s condition was constantly deteriorating. While receiving conventional drug therapy, patients are also treated with HBO therapy, in which they inhaled 100% oxygen at 2.5 atmospheres once a day for 90 minutes. The patient began to recover after 10 days of HBO therapy, and his hearing returned to normal after 20 days.
Studies have shown that the efficacy of HBO therapy is time dependent and that its effectiveness diminishes as the delay in administration increases.69 HBO therapy is most effective within 2 weeks after SSNHL occurs. Under conditions of ischemia and hypoxia, the generation of ROS increases. ROS can directly damage inner ear hair cells or indirectly damage hearing by promoting the expression of proinflammatory factors such as IL-6 and tumor necrosis factor α. ROS can also activate the c-Jun N-terminal kinase pathway to induce hair cell apoptosis. Moreover, HBO therapy can reduce damage to the inner ear via the Toll-like receptor 4-, tumor necrosis factor α- and nuclear factor κB-mediated inflammatory response by inhibiting the release of endogenous ligands.69 For patients who are unresponsive to steroid therapy, HBO therapy also remains an effective treatment option70 (Figure 6).
Figure 6.

Mechanism of hyperbaric oxygen therapy for sudden sensorineural hearing loss.
Some of the image materials are from biogdp.com.
Hyperbaric oxygen therapy for heart failure after cardiovascular surgery
Heart failure refers to a syndrome in which the pumping function of the heart is impaired for various reasons and in which the cardiac output cannot meet the basic metabolic needs of the body’s tissues. Patients might develop symptoms such as palpitations, fatigue, shortness of breath, and lower limb edema. A total of 10–20% of patients are readmitted after cardiovascular surgery due to heart failure.71,72
Leitman et al.46 found that HBO therapy can improve myocardial function in patients to treat heart failure. In their studies, patients received 90 minutes of HBO therapy at 2 ATA per day for 60 days. Transthoracic echocardiography was performed on all patients before and after HBO therapy. They reported that the left ventricular ejection fraction increased from 60.71 ± 6.02% to 62.29 ± 5.19%. The left ventricular end-systolic volume decreased from 38.08 ± 13.30 mL to 35.39 ± 13.32 mL. The myocardial function index decreased from 0.29 ± 0.07 to 0.26 ± 0.08. Simultaneously, improvements in function in apical rotation were observed. The improvements in these functions suggest that HBO therapy can promote the enhancement of cardiac contractility and improve patients with systolic heart failure. In addition, Aparci et al.73 found that HBO therapy can improve diastolic heart failure in diabetes patients. Studies have shown that HBO therapy can also improve the cardiac diastolic function of patients with diabetes.9,74
Continuous and regular HBO therapy can result in a cycle of high oxygen and relatively low oxygen during intervals. During periods of relative hypoxia, the levels of matrix metalloproteinases, vascular endothelial growth factor, HIF-1α, and other factors increase. Moreover, stem cell proliferation is promoted, inducing the generation of microvessels to improve local microcirculation. HBO therapy can also increase the generation of myocardial ATP, alleviate inflammatory reactions, improve endothelial dysfunction, and increase perfusion of the hypertrophic myocardium.46
Conclusions
On the basis of the preceding text, HBO clearly holds significant value in the perioperative period for cardiovascular surgery. HBO can be utilized as a safe and effective method for preconditioning patients prior to surgical intervention and as a therapeutic approach during postoperative recovery. HBO therapy has also been associated with a reduced incidence of perioperative complications, improved outcomes and shorter hospital stays. This not only benefits individual patients but also alleviates the burden on healthcare systems by optimizing resource utilization.
However, some limitations should be noted. First, there remains a notable scarcity of literature specifically addressing its application within this field. Second, current studies may not be able to provide comprehensive data regarding dosage protocols, timing of administration and long-term effects posttreatment. Third, studies in these fields are not comprehensive and rarely involve the molecular mechanisms underlying the effectiveness of HBO therapy. In the future, further prospective clinical trials are needed to confirm the effectiveness of HBO in the perioperative period of cardiovascular surgery and broaden its clinical application. We believe that alongside ongoing advancements in technology, the potential benefits of HBO may extend far beyond current expectations.
Funding Statement
Funding: This work was supported by the Beijing Chao-Yang Hospital Multidisciplinary Team Program (No. CYDXK 202208) and the Capital Medical University Undergraduate Research Innovation Project (No. XSKY2024329).
Footnotes
Conflicts of interest: None declared.
Data availability statement:
Not applicable.
References
- 1.Castro RCC, Costa PN, Rocha EAV, Ribeiro I, Parreira MP. Lymphocyte levels and morbidity and mortality in cardiovascular surgery with cardiopulmonary bypass. Braz J Cardiovasc Surg. 2024;39:e20230136. doi: 10.21470/1678-9741-2023-0136. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Marcello M, Virzì GM, Muciño-Bermejo MJ, et al. Subclinical AKI and clinical outcomes in elderly patients undergoing cardiac surgery: diagnostic utility of NGAL versus standard creatinine increase criteria. Cardiorenal Med. 2022;12:94–105. doi: 10.1159/000525221. [DOI] [PubMed] [Google Scholar]
- 3.Tamargo C, Hanouneh M, Cervantes CE. Treatment of acute kidney injury: a review of current approaches and emerging innovations. J Clin Med. 2024;13:2455. doi: 10.3390/jcm13092455. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Mills C, Bryson P. The role of hyperbaric oxygen therapy in the treatment of sternal wound infection. Eur J Cardiothorac Surg. 2006;30:153–159. doi: 10.1016/j.ejcts.2006.03.059. [DOI] [PubMed] [Google Scholar]
- 5.Banjanovic B, Karabdic IH, Straus S, Berberovic BH, Djedovic M, Granov N. Deep sternal wound infection after open-heart cardiac surgery and vacuum-assisted closure therapy: a single-center study. Med Arch. 2022;76:273–277. doi: 10.5455/medarh.2022.76.273-277. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Negargar S, Sadeghi S. Early postoperative cardiac complications following heart transplantation. Galen Med J. 2023;12:e2701. doi: 10.31661/gmj.v12i.2701. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Meerman M, Buijser M, van den Berg L, et al. Magnesium sulphate to prevent perioperative atrial fibrillation in cardiac surgery: a randomized clinical trial: a protocol description of the PeriOperative Magnesium Infusion to Prevent Atrial fibrillation Evaluated (POMPAE) trial. Trials. 2024;25:540. doi: 10.1186/s13063-024-08368-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Hshieh TT, Yue J, Oh E, et al. Effectiveness of multicomponent nonpharmacological delirium interventions: a meta-analysis. JAMA Intern Med. 2015;175:512–520. doi: 10.1001/jamainternmed.2014.7779. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Ozbay MB, Bhatt N, Duazo C, Kotkin SA, Thachil R. An incidental finding of a massive loculated pericardial effusion in a patient presenting with inferior ST-elevation myocardial infarction. Cureus. 2024;16:e62491. doi: 10.7759/cureus.62491. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Wei P, Yang F, Li J. PD-1 immune checkpoint blockade may be viable for the prevention and treatment of elderly patients with POCD [Letter] Clin Interv Aging. 2019;14:689–691. doi: 10.2147/CIA.S197925. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Rahman SH, Mazlan M, Suhaimi A, Hashim NHM. Identifying postoperative cognitive dysfunction after elective coronary artery bypass graft surgery in a tertiary center in Malaysia. Med J Malaysia. 2024;79:483–486. [PubMed] [Google Scholar]
- 12.Tamaki A, Silverman DA, Ozer E. The role of hyperbaric oxygen in head and neck reconstruction and facial cosmetic surgery. Facial Plast Surg. 2020;36:753–759. doi: 10.1055/s-0040-1717095. [DOI] [PubMed] [Google Scholar]
- 13.Wu X, You J, Chen X, et al. An overview of hyperbaric oxygen preconditioning against ischemic stroke. Metab Brain Dis. 2023;38:855–872. doi: 10.1007/s11011-023-01165-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Hu Q, Manaenko A, Matei N, et al. Hyperbaric oxygen preconditioning: a reliable option for neuroprotection. Med Gas Res. 2016;6:20–32. doi: 10.4103/2045-9912.179337. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Alex J, Laden G, Cale AR, et al. Pretreatment with hyperbaric oxygen and its effect on neuropsychometric dysfunction and systemic inflammatory response after cardiopulmonary bypass: a prospective randomized double-blind trial. J Thorac Cardiovasc Surg. 2005;130:1623–1630. doi: 10.1016/j.jtcvs.2005.08.018. [DOI] [PubMed] [Google Scholar]
- 16.Soejima Y, Ostrowski RP, Manaenko A, Fujii M, Tang J, Zhang JH. Hyperbaric oxygen preconditioning attenuates hyperglycemia enhanced hemorrhagic transformation after transient MCAO in rats. Med Gas Res. 2012;2:9. doi: 10.1186/2045-9912-2-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Yin X, Wang X, Fan Z, et al. Hyperbaric oxygen preconditioning attenuates myocardium ischemia‒reperfusion injury through upregulation of heme oxygenase 1 expression: PI3K/Akt/Nrf2 pathway involved. J Cardiovasc Pharmacol Ther. 2015;20:428–438. doi: 10.1177/1074248414568196. [DOI] [PubMed] [Google Scholar]
- 18.Jeysen ZY, Gerard L, Levant G, Cowen M, Cale A, Griffin S. Research report: The effects of hyperbaric oxygen preconditioning on myocardial biomarkers of cardioprotection in patients having coronary artery bypass graft surgery. Undersea Hyperb Med. 2011;38:175–185. [PubMed] [Google Scholar]
- 19.Nesovic Ostojic J, Kovacevic S, Ivanov M, et al. Hyperbaric oxygen reduces oxidative stress impairment and DNA damage and simultaneously increases HIF-1α in ischemia‒reperfusion acute kidney injury. Int J Mol Sci. 2024;25:3870. doi: 10.3390/ijms25073870. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Jugdutt BI. Nitric oxide and cardioprotection during ischemia‒reperfusion. Heart Fail Rev. 2002;7:391–405. doi: 10.1023/a:1020718619155. [DOI] [PubMed] [Google Scholar]
- 21.Russo I, Barale C, Melchionda E, Penna C, Pagliaro P. Platelets and cardioprotection: the role of nitric oxide and carbon oxide. Int J Mol Sci. 2023;24:6107. doi: 10.3390/ijms24076107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Zhao Q, Wan H, Pan H, Xu Y. Postoperative cognitive dysfunction-current research progress. Front Behav Neurosci. 2024;18:1328790. doi: 10.3389/fnbeh.2024.1328790. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Gao ZX, Rao J, Li YH. Hyperbaric oxygen preconditioning improves postoperative cognitive dysfunction by reducing oxidant stress and inflammation. Neural Regen Res. 2017;12:329–336. doi: 10.4103/1673-5374.200816. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Schoonen A, van Klei WA, van Wolfswinkel L, van Loon K. Definitions of low cardiac output syndrome after cardiac surgery and their effect on the incidence of intraoperative LCOS: a literature review and cohort study. Front Cardiovasc Med. 2022;9:926957. doi: 10.3389/fcvm.2022.926957. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Marcinkowska AB, Mankowska ND, Kot J, Winklewski PJ. Impact of hyperbaric oxygen therapy on cognitive functions: a systematic review. Neuropsychol Rev. 2022;32:99–126. doi: 10.1007/s11065-021-09500-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Sun L, Xie K, Zhang C, Song R, Zhang H. Hyperbaric oxygen preconditioning attenuates postoperative cognitive impairment in aged rats. Neuroreport. 2014;25:718–724. doi: 10.1097/WNR.0000000000000181. [DOI] [PubMed] [Google Scholar]
- 27.Hong-Qiang H, Mang-Qiao S, Fen X, et al. Sirt1 mediates improvement of isoflurane-induced memory impairment following hyperbaric oxygen preconditioning in middle-aged mice. Physiol Behav. 2018;195:1–8. doi: 10.1016/j.physbeh.2018.07.017. [DOI] [PubMed] [Google Scholar]
- 28.Luo SG, Chen HM, Tan RB, Li RZ. Effects of hyperbaric oxygen preconditioning combined with Edaravone on neurocognitive function, quality of life and the levels of inflammatory factors in patients after cardiac valve replacement. Zhongguo Yiyao Daobao. 2016;13:29–32. [Google Scholar]
- 29.Wu F, Zhou K, Gao F, et al. Cerebral protective effects of hyperbaric oxygen preconditioning on patients undergoing cardiac valve replacement. Zhongguo Tiwai Xunhun Zazhi. 2015;13:90–93. [Google Scholar]
- 30.Chen L, Sun XQ, Ren L, et al. Protective effect of combined preconditioning with hyperbaric oxygen and remote ischemia on brain after cardiac valve replacement surgeries. ZHongguo Xiandai Yixue Zazhi. 2018;28:58–63. [Google Scholar]
- 31.Cabezon G, Pulido P, López Díaz J, et al. Embolic events in infective endocarditis: a comprehensive review. Rev Cardiovasc Med. 2024;25:97. doi: 10.31083/j.rcm2503097. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Im SMS, Cañete MTA. Predictors for hemorrhagic transformation among patients with ischemic stroke admitted in a tertiary hospital in the Philippines from July 2018-July 2019. Acta Med Philipp. 2024;58:40–46. doi: 10.47895/amp.vi0.6748. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Hausenloy DJ, Yellon DM. Myocardial ischemia‒reperfusion injury: a neglected therapeutic target. J Clin Invest. 2013;123:92–100. doi: 10.1172/JCI62874. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Li Y, Dong H, Chen M, et al. Preconditioning with repeated hyperbaric oxygen induces myocardial and cerebral protection in patients undergoing coronary artery bypass graft surgery: a prospective, randomized, controlled clinical trial. J Cardiothorac Vasc Anesth. 2011;25:908–916. doi: 10.1053/j.jvca.2011.06.017. [DOI] [PubMed] [Google Scholar]
- 35.Yogaratnam JZ, Laden G, Guvendik L, Cowen M, Cale A, Griffin S. Hyperbaric oxygen preconditioning improves myocardial function, reduces length of intensive care stay, and limits complications post coronary artery bypass graft surgery. Cardiovasc Revasc Med. 2010;11:8–19. doi: 10.1016/j.carrev.2009.03.004. [DOI] [PubMed] [Google Scholar]
- 36.Migita H, Yoshitake S, Tange Y, Choijookhuu N, Hishikawa Y. Hyperbaric oxygen therapy suppresses apoptosis and promotes renal tubular regeneration after renal ischemia/reperfusion injury in rats. Nephrourol Mon. 2016;8:e34421. doi: 10.5812/numonthly.34421. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Jabayeva N, Bekishev B, Lesbekov T, et al. Impact of extracorporeal hemoadsorption during prolonged cardiopulmonary bypass on the incidence of acute kidney injury. J Extra Corpor Technol. 2024;56:45–54. doi: 10.1051/ject/2024004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Banerjee D, Feng J, Sellke FW. Strategies to attenuate maladaptive inflammatory response associated with cardiopulmonary bypass. Front Surg. 2024;11:1224068. doi: 10.3389/fsurg.2024.1224068. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Gaudino M, Angelini GD, Antoniades C, et al. Off-pump coronary artery bypass grafting: 30 years of debate. J Am Heart Assoc. 2018;7:e009934. doi: 10.1161/JAHA.118.009934. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Saemann L, Zubarevich A, Wenzel F, et al. Central and peripheral circulation differ during off-pump coronary artery bypass grafting. Rev Cardiovasc Med. 2024;25:30. doi: 10.31083/j.rcm2501030. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Ma T, Chen WS, Li T, Zhang YH, Liu XG, Ouyang H. Proceedings of the National Conference on Cardiac Valve Surgery. Huangshan: 2005. Treatment of hypoxic encephalopathy after heart valve replacement. [Google Scholar]
- 42.Petzold T, Feindt PR, Carl UM, Gams E. Hyperbaric oxygen therapy in deep sternal wound infection after heart transplantation. Chest. 1999;115:1455–1458. doi: 10.1378/chest.115.5.1455. [DOI] [PubMed] [Google Scholar]
- 43.Lerche CJ, Christophersen LJ, Kolpen M, et al. Hyperbaric oxygen therapy augments tobramycin efficacy in experimental Staphylococcus aureus endocarditis. Int J Antimicrob Agents. 2017;50:406–412. doi: 10.1016/j.ijantimicag.2017.04.025. [DOI] [PubMed] [Google Scholar]
- 44.Yacoub MH, Zeitlin GL. Hyperbaric oxygen in the treatment of the postoperative low-cardiac-output syndrome. Lancet. 1965;1:581–583. doi: 10.1016/s0140-6736(65)91150-5. [DOI] [PubMed] [Google Scholar]
- 45.Bruschi G, Tarelli G, Colombo P, et al. Effectiveness of hyperbaric oxygen therapy for hearing loss after cardiac surgery. Ann Thorac Surg. 2007;83:e9–10. doi: 10.1016/j.athoracsur.2007.01.050. [DOI] [PubMed] [Google Scholar]
- 46.Leitman M, Efrati S, Fuchs S, Hadanny A, Vered Z. The effect of hyperbaric oxygenation therapy on myocardial function. Int J Cardiovasc Imaging. 2020;36:833–840. doi: 10.1007/s10554-020-01773-0. [DOI] [PubMed] [Google Scholar]
- 47.Willems LM, Trienekens F, Knake S, et al. EEG patterns and their correlations with short- and long-term mortality in patients with hypoxic encephalopathy. Clin Neurophysiol. 2021;132:2851–2860. doi: 10.1016/j.clinph.2021.07.026. [DOI] [PubMed] [Google Scholar]
- 48.Dean BS, Verdile VP, Krenzelok EP. Coma reversal with cerebral dysfunction recovery after repetitive hyperbaric oxygen therapy for severe carbon monoxide poisoning. Am J Emerg Med. 1993;11:616–618. doi: 10.1016/0735-6757(93)90016-5. [DOI] [PubMed] [Google Scholar]
- 49.Dexter F, Hindman BJ. Recommendations for hyperbaric oxygen therapy of cerebral air embolism based on a mathematical model of bubble absorption. Anesth Analg. 1997;84:1203–1207. doi: 10.1097/00000539-199706000-00006. [DOI] [PubMed] [Google Scholar]
- 50.Armon C, Deschamps C, Adkinson C, Fealey RD, Orszulak TA. Hyperbaric treatment of cerebral air embolism sustained during an open-heart surgical procedure. Mayo Clin Proc. 1991;66:565–571. doi: 10.1016/s0025-6196(12)60514-x. [DOI] [PubMed] [Google Scholar]
- 51.Yu YJ, Tu CQ, Xie XM, Huang QF, Long Y. Clinical observation of hyperbaric oxygen assisted treatment for cerebral embolism after heart valve replacement. Zhongguo Kangfu Yixue Zazhi. 2008;23:460–461. [Google Scholar]
- 52.Blanc P, Boussuges A, Henriette K, Sainty JM, Deleflie M. Iatrogenic cerebral air embolism: importance of an early hyperbaric oxygenation. Intensive Care Med. 2002;28:559–563. doi: 10.1007/s00134-002-1255-0. [DOI] [PubMed] [Google Scholar]
- 53.Varpaei HA, Farhadi K, Mohammadi M, Khafaee Pour Khamseh A, Mokhtari T. Postoperative cognitive dysfunction: a concept analysis. Aging Clin Exp Res. 2024;36:133. doi: 10.1007/s40520-024-02779-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Linassi F, Maran E, De Laurenzis A, et al. Targeted temperature management in cardiac surgery: a systematic review and meta-analysis on postoperative cognitive outcomes. Br J Anaesth. 2022;128:11–25. doi: 10.1016/j.bja.2021.09.042. [DOI] [PubMed] [Google Scholar]
- 55.Li DJ, Chen Y, Chen YE. The effect of hyperbaric oxygen therapy on the prognosis of postoperative cerebrovascular disease in patients with heart disease. Xiandai Yiyao Weisheng. 2012;28:2239–2240. [Google Scholar]
- 56.Tiew TC, Md Ali NA, Ismail MI, Abdul Rahman MR, Ding CH, Tzar MN. Successful treatment of sternal osteomyelitis and mediastinitis caused by rhizopus following cardiac surgery. Cureus. 2024;16:e62312. doi: 10.7759/cureus.62312. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Ma X, Chen D, Liu J, et al. Risk factors for sternal wound infection after median sternotomy: A nested case‒control study and time-to-event analysis. Int Wound J. 2024;21:e14965. doi: 10.1111/iwj.14965. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Egito JG, Abboud CS, Oliveira AP, et al. Clinical evolution of mediastinitis in patients undergoing adjuvant hyperbaric oxygen therapy after coronary artery bypass surgery. Einstein (Sao Paulo) 2013;11:345–349. doi: 10.1590/S1679-45082013000300014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Sun IF, Lee SS, Chiu CC, Lin SD, Lai CS. Hyperbaric oxygen therapy with topical negative pressure: an alternative treatment for the refractory sternal wound infection. J Card Surg. 2008;23:677–680. doi: 10.1111/j.1540-8191.2008.00689.x. [DOI] [PubMed] [Google Scholar]
- 60.Park MK, Myers RA, Marzella L. Oxygen tensions and infections: modulation of microbial growth, activity of antimicrobial agents, and immunologic responses. Clin Infect Dis. 1992;14:720–740. doi: 10.1093/clinids/14.3.720. [DOI] [PubMed] [Google Scholar]
- 61.Hedetoft M, Garred P, Madsen MB, Hyldegaard O. Hyperbaric oxygen treatment is associated with a decrease in cytokine levels in patients with necrotizing soft-tissue infection. Physiol Rep. 2021;9:e14757. doi: 10.14814/phy2.14757. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Kahrovic A, Herkner H, Angleitner P, et al. Automated titanium fastener for surgical aortic valve replacement-preventive role for infective endocarditis? Eur J Cardiothorac Surg. 2024:65. doi: 10.1093/ejcts/ezae236. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Lerche CJ, Schwartz F, Theut M, et al. Anti-biofilm approach in infective endocarditis exposes new treatment strategies for improved outcome. Front Cell Dev Biol. 2021;9:643335. doi: 10.3389/fcell.2021.643335. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Memar MY, Yekani M, Alizadeh N, Baghi HB. Hyperbaric oxygen therapy: Antimicrobial mechanisms and clinical application for infections. Biomed Pharmacother. 2019;109:440–447. doi: 10.1016/j.biopha.2018.10.142. [DOI] [PubMed] [Google Scholar]
- 65.Oter S, Edremitlioglu M, Korkmaz A, et al. Effects of hyperbaric oxygen treatment on liver functions, oxidative status and histology in septic rats. Intensive Care Med. 2005;31:1262–1268. doi: 10.1007/s00134-005-2701-6. [DOI] [PubMed] [Google Scholar]
- 66.Lomivorotov VV, Efremov SM, Kirov MY, Fominskiy EV, Karaskov AM. Low-cardiac-output syndrome after cardiac surgery. J Cardiothorac Vasc Anesth. 2017;31:291–308. doi: 10.1053/j.jvca.2016.05.029. [DOI] [PubMed] [Google Scholar]
- 67.Epting CL, McBride ME, Wald EL, Costello JM. Pathophysiology of postoperative low cardiac output syndrome. Curr Vasc Pharmacol. 2016;14:14–23. doi: 10.2174/1570161113666151014123718. [DOI] [PubMed] [Google Scholar]
- 68.Psillas G. Hyperbaric oxygen therapy in the treatment of sudden sensorineural hearing loss. J Clin Med. 2023;12:1515. doi: 10.3390/jcm12041515. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Hu Y, Ye Y, Ji X, Wu J. The role of hyperbaric oxygen in idiopathic sudden sensorineural hearing loss. Med Gas Res. 2024;14:180–185. doi: 10.4103/2045-9912.385943. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Wang HH, Chen YT, Chou SF, et al. Effect of the timing of hyperbaric oxygen therapy on the prognosis of patients with idiopathic sudden sensorineural hearing loss. Biomedicines. 2023;11:2670. doi: 10.3390/biomedicines11102670. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Sabe SA, Sabe MA, Kennedy KF, Sellke FW, Ehsan A. Risk factors for heart failure readmission after cardiac surgery. JACC Adv. 2023;2:100599. doi: 10.1016/j.jacadv.2023.100599. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Guerrero-Orriach JL, Carmona-Luque MD, Gonzalez-Alvarez L. Heart failure after cardiac surgery: the role of halogenated agents, myocardial conditioning and oxidative stress. Int J Mol Sci. 2022;23:1360. doi: 10.3390/ijms23031360. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Aparci M, Kardesoglu E, Suleymanoglu S, et al. Hyperbaric oxygen therapy improves myocardial diastolic function in diabetic patients. Tohoku J Exp Med. 2008;214:281–289. doi: 10.1620/tjem.214.281. [DOI] [PubMed] [Google Scholar]
- 74.Alsaddique AA, Royse AG, Royse CF, Fouda MA. Management of diastolic heart failure following cardiac surgery. Eur J Cardiothorac Surg. 2009;35:241–249. doi: 10.1016/j.ejcts.2008.10.038. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
Not applicable.
